The biotech company Moderna announced Monday that its coronavirus vaccine is 94.5% effective, according to early data. This comes a week after Pfizer announced that the vaccine it’s developing is more than 90% effective, encouraging news as the number of coronavirus cases is surging in the United States and Europe.
Here & Now‘s Tonya Mosley speaks with Dr. Gregory Poland, director of the Mayo Clinic’s Vaccine Research Group.
This article was originally published on WBUR.org.
Copyright 2020 NPR. To see more, visit https://www.npr.org. 9(MDA5MTc0MDI0MDEzMzE4MjI4ODdlOTk4MA004))